We report an interaction between oligodendroglia and vasculature in MS that distinguishes human white matter injury from normal rodent demyelinating injury. We find perivascular clustering of oligodendrocyte precursor cells (OPCs) in certain active MS lesions, representing an inability to properly detach from vessels following perivascular migration. Perivascular OPCs can themselves disrupt the BBB, interfering with astrocyte endfeet and endothelial tight junction integrity, resulting in altered vascular permeability and an associated CNS inflammation. Aberrant Wnt tone in OPCs mediates their dysfunctional vascular detachment and also leads to OPC secretion of Wif1, which interferes with Wnt ligand function on endothelial tight junction integrity. Evidence for this defective oligodendroglial-vascular interaction in MS suggests that aberrant OPC perivascular migration not only impairs their lesion recruitment but can also act as a disease perpetuator via disruption of the BBB. 
M
S is an autoimmune disease of the CNS associated with demyelination and axonal loss that eventually leads to neurodegeneration, and exhibits many of the features of an inflammatory autoimmune disorder including breakdown of the BBB. BBB disruption is one of the earliest cerebrovascular abnormalities in MS, allowing unrestricted access of immune cells and blood-borne components into the CNS which play a central role in demyelination and axonal damage [1] [2] [3] [4] [5] . Regeneration of damaged myelin can occur initially, involving a recruitment of migrating OPCs into areas of demyelination from surrounding normal-appearing white matter (NAWM) followed by their differentiation into mature oligodendrocytes 6, 7 , but remyelination is not durable and can fail at either of these stages [8] [9] [10] . Recurrence of BBB breakdown may occur at the same or different locations within intervals of weeks or months, with lesions developing irregularly with additional phases of BBB leakage, immunologically mediated demyelination, and axonal transection. Contributors to BBB dysregulation during the disease are not fully understood. We report here a pathological finding in MS, suggesting a dysfunctional interaction between OPCs and the vasculature, and question its cause and its implication.
Results

Aberrant perivascular clustering of OPCs in MS.
MS is characterized by immune infiltration of cells across the BBB into brain parenchyma, and perivascular accumulation of inflammatory cells. Analysis in certain active MS ( Fig. 1a and Supplementary Table 1) lesions, however, identifies perivascular clusters of cells around CD31 + vasculature (Fig. 1b -j,l), which separate from markers for inflammatory cells (Fig. 1d) . These perivascular clusters express the oligodendroglial marker OLIG2 (Fig. 1e ,f,h,i) and the marker NKX2.2 ( Fig. 1l) . They also express the Wnt pathway marker RNF43 ( Fig. 1g and Supplementary Fig. 1a-c) , previously shown to be a target of Wnt in OPCs that is activated under high Wnt tone 11, 12 , and have the typical bipolar morphology of OPCs. Perivascular OPC clusters were not seen in NAWM (Fig. 1n) or normal-appearing gray matter (NAGM) (Fig. 1m ) from the MS patients analyzed, and while isolated OPCs are often seen in close association with blood vessels in the core of chronic MS lesions (Fig. 1j,k) , the finding of perivascular clustering is significantly more frequent in active inflammatory areas (Fig. 1o) . Cluster frequency, appearance, and size were variable, presumably reflecting significant differences in MS lesion age and history ( Fig. 1o and Supplementary Table 1) .
OPC perivascular clustering represents a defective single cell migration. The underlying cause of this pathological finding in MS is unclear. OPCs are known to associate intimately with vasculature during a developmental phase, where they use blood vessels as a critical physical scaffold for single cell migration 13 . They maintain the ability in adulthood to be activated and migrate significant distances in response to injuries, and we find that they retain this capacity for single cell perivascular migration in remyelination ( Fig. 3g ).
OPCs use single cell perivascular migration for their recruitment into areas of demyelination, and their perivascular clustering is therefore not a feature that is seen in wild-type (WT) murine white matter injury. OPC association with blood vessels during murine developmental migration is mediated by a Wnt-driven upregulation of Cxcr4 in OPCs 13 , and the finding of individual perivascular OLIG2
+ cells expressing CXCR4 in human white matter injury ( Supplementary Fig. 3i ) suggests a conserved mechanism of attraction to the endothelium. To address whether the perivascular clustering of OPCs in MS represents a dysfunctional migration, and an involvement for overactive Wnt signaling in this aberrant vascular interaction, we performed focal demyelination in adult inducible (Fig. 2g) mice. These clusters are not seen in control littermate remyelination (Fig. 2a,b,e) , and have excessive Wnt tone evidenced by significantly increased Axin2 messenger RNA expression ( Supplementary Fig. 5a-d ) and GFP expression in PDGFRa-creERT2:APC loxP/loxP :Rosa-GFP ( Fig. 2h and Supplementary  Fig. 5e,f) . We find reduced OPC numbers at early 3-dpl time points in lesion centers in both PDGFRa-creERT2:APC loxP/loxP ( Supplementary Fig. 6a ,c) (P = 0.0003) and Olig2-cre:APC loxP/loxP mice ( Supplementary Fig. 6a ,b) (P = 0.0013), without effects on OPC proliferation ( Supplementary Fig. 6e-h ), suggesting that an increased OPC association with vasculature ( Supplementary Fig.  6d ), in the form of perivascular clusters (Fig. 2e ), leads to a reduced ability for proper recruitment to the lesion core. These results indicate that OPC perivascular clustering following demyelination represents an aberrant OPC migration on vessels and is mediated by defective Wnt signaling.
OPC perivascular clusters disrupt the BBB. We questioned how this dysfunctional OPC perivascular migration and vascular Rosa-GFP mice (h), at 10-dpl lesion edges following focal lysolecithin injection into spinal cord dorsal funiculus white matter. Scale bars, 20 μm in all panels. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. Values are mean ± s.d.
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NAturE NEurOSCiENCE detachment failure affects the integrity of the underlying vessel. Injury models themselves cause significant vascular damage. We therefore required a non-injury model to identify the specific effects of an OPC perivascular cluster in the absence of any injury-induced vascular disruption. We used Olig2-cre:APC loxP/loxP mice, which have defective OPC vascular detachment postnatally, with perivascular accumulations appearing in a non-injury setting that closely resemble the clusters seen in both human white matter injury ( Supplementary Fig. 7 ) and following demyelination in PDGFRacreERT2:APC loxP/loxP and Olig2-cre:APC loxP/loxP . In this non-injury setting, we find that aberrant oligodendroglial-vascular interactions interfere with several aspects of BBB integrity. OPC perivascular clusters interfere with astrocyte-vascular interactions by altering the positioning of astrocyte endfeet on vasculature. Use of Aldh1l1-GFP mice (which label astrocytes and their endfeet) (Fig. 3a) , shows that, when crossed into Olig2-cre:APC loxP/loxP mice, there are significant astrocyte endfeet placement deficits (P = 1.56 × 10 ) in areas where OPCs are clustered around blood vessels (Fig. 3b,c,g ). Threedimensional (3D) reconstruction of astrocytes and OPCs on vessels in Olig2-cre:APC loxP/loxP :TdTomato:Aldh1l1-GFP mice suggests a competition for space on the vessel surface and a physical displacement of astrocyte processes from vasculature at sites of OPC clustering ( Fig. 3d-f ). This is also seen as significant gaps in staining for Aquaporin-4 (Aqp4) ( ), a water channel highly enriched in astrocyte endfeet at the BBB. 3D reconstruction of perivascular clusters from 10-dpl lesion edges in PDGFRa-creERT2:APC loxP/loxP mice following focal demyelination ( Supplementary Fig. 9 ) suggests a similar mechanism of endfoot displacement, whereby the processes of perivascular clustered OPCs can actually exist between endothelial cells (ECs) and overlying astrocyte endfeet.
In addition to astrocyte disruption, OPC perivascular clusters also cause EC dysfunction. Staining for plasmalemma vesicleassociated protein (PLVAP), a structural component of endothelial fenestrae, but gaps in staining for claudin5 (Cldn5) (Fig. 4a-c) , a structural component of EC tight junctions, identifies areas of nonintact BBB around OPC clusters (Fig. 4a-c) . In contrast to astrocyte coverage, pericyte coverage of vessels seems unaffected by OPC clustering ( Supplementary Fig. 10 ), but does not rule out functional deficits in these cells. The effects on astrocyte endfoot placement and EC tight junction integrity suggested possible effects on the barrier function of the BBB. We assessed leakage of the soluble 340-kDa serum glycoprotein fibrinogen from vessels, as well as leakage of a 10-kDa dextran-tetramethylrhodamine tracer 6 hours post tail vein injection. Both of these are detectable only within the lumen of vessels in control mice (Fig. 4d,g ), but there are significant increases in the amount seen in CNS parenchyma around OPC clusters (arrows in Fig. 4e ), suggesting extravasation of blood components and further supporting the notion that BBB integrity is affected at these areas.
OPC perivascular clusters trigger a CNS inflammation. OPC effects on the barrier function of the BBB trigger a CNS inflammatory reaction. We found increased numbers of cells expressing Iba1 (which stains microglia and macrophages) which have a less processed and more globose morphology ( Supplementary Fig. 11a,  b) . Pronounced CD11c and F4/80 staining in cells around perivascular OPCs (Fig. 5a,b,d and Supplementary Fig. 11b ), which is not present in control littermate mouse brains (Fig. 5a,b,d and Supplementary Fig. 11a ), also identifies activated microglia/macrophages. These cells expressed high levels of iNOS rather than Arg-1 ( Supplementary Fig. 11b ), suggesting an M1-polarized population. Use of Cx3cr1-GFP:CCR2-RFP mice crossed into the Olig2-cre:APC loxP/loxP suggests that this represents predominantly a microglial activation (Fig. 5c and Supplementary Fig. 11c, d ) rather than recruitment of activated macrophages from the circulation. However, small numbers of RFP + macrophages (in the CCR2-RFP mice, Supplementary Fig. 11d , e) and CD3-expressing T cells, including CD4 and CD8 subsets, were observed within the perivascular clusters (Fig. 5e-g ), suggesting extravasation of inflammatory cells into surrounding brain parenchyma in addition to protein leakage. Effects on the barrier function of the BBB lead to injury to both surrounding axons and perivascular OPCs. SMI32
+ axonal spheroids, indicating swellings of damaged axons, are significantly increased (P = 0.0286) and identify axonal degeneration adjacent to perivascular clusters ( Fig. 5h-j) . OPCs themselves also undergo significant cell death within clusters (P = 0.0009) (Fig. 5l-n) , leading to a resolution over time of the aggregations ( Fig. 5k and Supplementary Fig. 12a-c) , with reinvestment of astrocyte endfeet ( Fig. 3c and Supplementary Fig. 12b ) on blood vessels and reduction in microglial activation ( Supplementary Fig. 12d ).
To further assess the contribution of OPC perivascular clusters as a cause of BBB disruption, we performed an in vivo pharmacological blockade of the chemokine mediating their vascular association. Postnatal treatment of Olig2-cre:APC loxP/loxP mice intravenously with the Cxcr4-Sdf1 inhibitor AMD3100 leads to significant reversal of OPC cluster size on vasculature (P = 1.04 × 10 + numbers (P = 0.0044) ( Supplementary Fig. 13m-o) . These results identify a requirement for the physical presence of OPC clusters on blood vessels for effects on vascular integrity, and show that failure of OPC detachment from vasculature can itself disrupt the BBB and trigger CNS inflammation, in an otherwise non-inflammatory setting.
Wnt inhibitory factor 1 (Wif1) production by Wnt-activated perivascular OPCs disrupts EC tight junctions. OPC perivascular clusters cause disruption of cells at the vascular surface, and their physical presence on vessels is required for BBB effects. We questioned how these perivascular OPCs might further contribute to effects on the barrier function of the BBB via local effects resulting from physical proximity to the endothelium. Excessive Wnt signaling in OPCs mediates their perivascular accumulation. To uncover factors upregulated in clustered perivascular OPCs that might have effects on neighboring endothelium, we performed RNA sequencing (RNAseq) profiling of spinal cord white matter from postnatal day 4 (P4) and P9 Olig2-cre:APC loxP/loxP mice ( Supplementary Fig. 14a ). Differential expression analysis compared with APC loxP/loxP controls identified 270 genes significantly altered (false discovery rate (FDR) < 0.05) at P4 (43 upregulated and 227 downregulated genes in Olig2-cre:APC loxP/loxP ) ( Supplementary Fig. 14b ), and 4,505 genes at P9 (2,092 up and 2,413 down in Olig2-cre:APC loxP/loxP ). We identified Wif1 as the most upregulated secreted factor in this tissue at both time points (FDR < 2.13 × 10 −63 at P4, FDR < 3.79 × 10 −89 at P9) ( Supplementary Fig. 14c ). We found Wif1 mRNA expression markedly increased in Wnt-activated perivascular OPCs in spinal cord ( Fig. 6a and Supplementary Fig. 15g ; P = 2.67 × 10 −5 ) and corpus callosum (Fig. 6b,d ) of Olig2-cre:APC loxP/loxP mice, in cultured OPCs from these same mice ( ), and in WT OPCs treated with Wnt3a ( Fig. 6c ; P = 0.0093). Wif1 protein was also significantly increased on western blot in OPCs isolated from Olig2-cre:APC loxP/loxP compared with controls ( Supplementary  Fig. 15a ,b) (P = 0.0286). WIF1 is also expressed by OPCs in MS lesions. We find WIF1 mRNA expression in OLIG2 + clusters in MS (Fig. 6e,f) , and evidence of WIF1 protein expressed by cells around the vasculature in active MS lesions ( Fig. 6g and Supplementary  Fig. 1d ). Wif1 is directly upregulated by Wnt signaling in a number of cell types, acting as a negative feedback control mechanism of Articles NAturE NEurOSCiENCE the pathway 12 . It is a secreted protein that functions as a paracrine inhibitor of the pathway by binding, and inhibiting the activity of, extracellular Wnt ligands 14 . As Wnt ligands are important for the induction and maintenance of barrier properties in ECs, establishing a paracrine loop that maintains the BBB [15] [16] [17] [18] , we reasoned that high local production of Wif1 by Wnt-activated perivascular OPCs might affect EC tight junction integrity. We found that treatment of primary CNS ECs with Wif1 significantly (P = 0.0235) reduced their expression of Cldn5 tight junctions (Fig. 6h-i and Supplementary Fig. 15c,d) , and counteracted the effects of Wnt ) in inducing barrier markers in these cells (Fig. 6h,i,m and Supplementary Fig. 15c,d ). This was accompanied by a reduction in Wnt tone in ECs (evidenced by significantly reduced Axin2 expression, P = 0.0338), and increased expression of the endothelial fenestrae marker PLVAP (P = 1.46 × 10 −11 ) (Fig. 6m) . Similar effects on tight junction formation, barrier marker expression, and Wnt tone in ECs were observed when treated with conditioned medium from Wnt hyperactive (Olig2-cre:APC loxP/loxP ) OPCs (Fig. 6j ,k,n and Supplementary Fig. 15e,f) . Selective depletion of secreted Wif1 protein from this conditioned medium, using anti-Wif1 antibody-mediated pull down (Fig. 6l) , prevented these effects on endothelium (Fig. 6j,k,n and Supplementary Fig. 15e,f ). Data were analyzed by unpaired two-sided Student's t-test. Scale bars, 20 μm in all panels. **P < 0.01, ***P < 0.001, ****P < 0.0001. Values are mean ± s.d. :TdTomato mice (n = 6 animals; P = 0.0009). Data were analyzed by unpaired two-sided Student's t-test. Scale bars, 10 μm (l), 20 μm (all other panels). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. Values are mean ± s.d.
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identifying it as the mediator of these effects on tight junction marker expression and Wnt pathway tone in ECs. Wif1 also functionally regulates the barrier properties of endothelium (Fig. 6o) , as Wif1 treatment of ECs in an in vitro BBB permeability assay significantly increases the permeability to a 10-kDa dextran-tetramethylrhodamine dye and significantly counteracts the action of Wnt ligands to reduce barrier permeability. Evidence of WIF1 expression in OLIG2 + clusters in human white matter injury (Fig.  6e-f) suggests that high local production of this Wnt inhibitor by perivascular OPCs may also contribute to dysfunction of EC barrier properties in MS.
Discussion
Recruitment of OPCs into areas of demyelination is a critical initial step for successful myelin regeneration, and dysfunction of this process contributes to remyelination failure in MS 10 . We show here that OPCs utilize single cell perivascular migration on microvessels for recruitment into murine demyelinated injury. This perivascular migration following injury appears to be a recapitulation of their developmental migration, where OPCs require a vascular scaffold for their dispersal through the CNS 13 . They show a significantly increased association with vasculature at lesion edges at early time points during remyelination, along with morphological changes more akin to their developmental counterparts. Live imaging studies in murine remyelination suggest a limited time window of OPC migration into lesions around 1.5 dpl, with the majority of OPC numbers in lesions made up from proliferation once they have migrated into the intralesional environment.
Completion of OPC perivascular migration requires their detachment from vessels to allow for oligodendrocyte differentiation and interaction with axonal targets. We find in several MS cases, in lesion areas with active inflammation, that OPCs can be found clustered on vasculature, representing a defect in single cell perivascular migration and inability to detach from blood vessels. We do not see this OPC perivascular clustering in WT murine remyelination, and it therefore seems to represent a feature that distinguishes human from murine white matter injury. This OPC perivascular clustering is mediated by aberrant Wnt tone in remyelination, as evidenced in . Importantly, it both affects proper OPC dispersal into remyelinating lesions and exposes them to further damage from blood-borne inflammatory insults.
Failure of OPC detachment from vasculature following migration represents a pathological oligodendroglial-vascular interaction and detrimentally affects the underlying vessel. We find in both development and remyelination that OPC perivascular clusters disrupt other cells at the microvessel surface, causing physical displacement of astrocyte endfeet from vessels, with the processes of clustered OPCs seeming to exist between endothelium and overlying astrocyte endfeet. While pericyte coverage seems unaltered, it will be important to assess how these cells might be functionally affected, considering critical roles in formation of the BBB 19 and emerging roles in CNS remyelination 20 . To determine the specific effects of these OPC clusters on the integrity of underlying vasculature, we had to make use of a non-injury model, as injury models by their very nature induce significant vascular disruption. We find, in an otherwise noninflammatory setting, that OPC perivascular clusters themselves cause endothelial disruption, and BBB integrity defects that trigger a subsequent CNS inflammation. Vascular integrity defects lead to damage to surrounding axons and perivascular OPCs, identifying OPC clusters themselves as contributors to pathology.
Pharmacological reversal of OPC perivascular clustering with AMD3100 (which inhibits the OPC-vascular Cxcr4/Sdf1 interaction without altering OPC Wnt tone) in vivo in Olig2-cre:APC loxP/loxP shows that these clusters are required for detrimental BBB effects, and moreover that their physical presence on vessels is necessary for these effects, presumably through disruption of cells at the vascular surface. In addition, we identify Wif1, previously reported to disrupt the BBB in Wnt-driven medulloblastoma 21 , as a factor secreted by OPCs in Wnt-driven perivascular clusters that may contribute to endothelial dysfunction in MS. Wif1 secreted by Wnt-activated OPCs acts to counteract the effects of Wnt ligands in promoting endothelial tight junction markers, acts to increase permeability of endothelium, and also acts to reduce Wnt tone in ECs. Considering that Wnt tone in CNS vessels has been implicated in the restoration ), and in isolated WT OPCs treated with Wnt3a compared with untreated controls (n = 3 independent experiments; **P = 0.0093). c, Data were analyzed by unpaired two-sided Student's t-test. d, Significantly upregulated Wif1 mRNA in vivo colocalizes with Olig2 protein in clustered cells in Olig2-cre:APC loxP/loxP corpus callosum. e,f, WIF1 is expressed by clustered OLIG2 + cells in MS active lesion white matter (f). g, WIF1 protein expression by cells around CD31 + vasculature (arrows) in MS lesion white matter. h,i, Tight junctions stained for Cldn5 protein in isolated CNS ECs treated with control PBS, Wif1, Wnt3a, or Wif1 + Wnt3a for 2 days (h), and Cldn5 fluorescent intensity sums (as fold change compared with PBS control) in EC cultures under these treatment conditions (i) (n = 4 independent experiments; PBS versus Wif1, *P = 0.0235; PBS versus Wnt3a, ****P = 2.59 × 10 ). Data were analyzed by one-way ANOVA. l, ELISA optical density values for Wif1 protein concentrations in conditioned medium from these groups (n = 4 independent experiments; WT-CM + BSA versus APC-CM + BSA, ****P = 6.79 ×10 −8 ; WT-CM +Ab versus APC-CM + Ab, ### P = 0.0002). Data were analyzed by one-way ANOVA. m,n, Fold change of mRNA in cultured ECs (by qPCR relative to control) for tight junction marker Cldn5, endothelial fenestrae marker PLVAP and Wnt pathway activation marker Axin2 in the Wif1/Wnt3a treatment groups from Fig. 4h (m) and the OPC conditioned medium treatment groups from Fig. 4j (n) . m, n = 4 independent experiments; Cldn5: PBS versus Wif1, *P = 0.0381; PBS versus Wnt3a, ****P = 3.86 × 10 ). Data were analyzed by one-way ANOVA. Scale bars, 90 μm (a, b), 20 μm (d left panel, g), and 10 μm (d right panel, e, f, h, j) . Values are mean ± s.d.
Articles
NAturE NEurOSCiENCE
of BBB integrity in MS, and also in limiting immune cell infiltration into the CNS 22 , the local production of Wif1 by dysregulated perivascular OPCs could further contribute to pathology in MS. There may be a variety of contributors to BBB dysregulation in MS that are not fully understood. It will be important to establish the contribution of this aberrant oligodendroglial-vascular interaction to the failed OPC recruitment seen in many MS lesions, and to perpetuation of disease through ongoing disruption of the BBB. 
online content
NG2-CreERT:
TdTomato. This mouse has been described previously 23 . We used 8-week-old mice to label OPCs in slice cultures. Before slice culture, the mice were given tamoxifen (T-5648, Sigma) gavage with 1 mg of tamoxifen twice a day for 5 consecutive days (10 mg in total).
Olig2-cre.
A multi-functional mouse line was constructed previously 24 by inserting tva, an avian-specific retroviral receptor, and an IRES-cre recombinase cassette into the endogenous Olig2 locus by homologous recombination. This Olig2-cre allows for cre-mediated activity in oligodendrocyte lineage cells.
PDGFRa-creERT2. These mice have been described previously 25 . A tamoxifen inducible cre recombinase gene was inserted into exon 2. These mice were used to cross with APC loxP/loxP mice. To knock out APC, the mouse was given tamoxifen gavage as described above.
APC loxP/loxP
. These mice have been described previously 26 . A conditional (loxPflanked) allele of APC was provided by Dr. R. Fodde (Leiden University). Through intercrosses with Olig2-cre or PDGFRa-CreERT2 recombinase we can achieve conditional knockout of APC in OPCs. We used a breeding strategy of crossing either Aldh1l1-GFP. These mice have been described previously 27 . The diffuse expression pattern of the Aldh1L1-GFP throughout the CNS is consistent with pan-astrocyte expression, which allows us to visualize the astrocyte processes and endfeet in our study.
Cx3cr1-GFP:CCR2-RFP. These mice have been described previously 28 . The Cx3cr1-GFP specifically labels microglia in the CNS, and CCR2-RFP labels macrophages. By using this reporter mouse, we are able to distinguish infiltrating macrophages from resident microglia within tissue sections.
Immunohistochemistry. The method has been described previously In situ hybridization. The technique has been described previously 29 . Briefly, digoxigenin (DIG)-labeled antisense Axin2, Cxcr4, Wif1, or PDGFRa probes were used. The targeted mRNA-expressing cells were visualized as a dark purple deposition with NBT/BCIP (nitro blue tetrazolium/5-bromo-4-chloro-3-indolyl phosphate)-alkaline phosphatase combination. Cell counting was performed under a ×10 objective lens for each sample using Image-Pro Plus software.
Lysolecithin lesioning. The method has been described previously 29 . Demyelinated lesions were produced in the dorsal funiculus spinal cord white matter of 8-10-week-old ) given subcutaneously. Having exposed the spinal vertebrae at the level of T12/T13, tissue was cleared overlying the intervertebral space, and the dura was pierced with a dental needle just lateral to midline. A Hamilton needle was advanced through the pierced dura at an angle of 45°, and 0.5 μl 1% lysolecithin (l-α-lysophosphatidylcholine) was injected into the dorsal funiculus white matter.
Live imaging of remyelination in slice culture. Demyelination was produced in mouse spinal cords in vivo, as described above. Live imaging was performed on slices taken from spinal cord lesions at various times after lysolecithin-induced demyelination in vivo. Images shown in Fig. 2 and Supplementary Figs. 2 and 3 were from slices of cord taken at 1.5 dpl. To label the shape of the vasculature, we injected Fluorescent-lectin (100 μl, Vector Labs DL-1174) via tail vein injection. After 10 min, allowing dye circulation, spinal cords were dissected immediately in ice-cold artificial cerebrospinal fluid. Spinal cords were then embedded in 5% low-melting-point agarose in artificial cerebrospinal fluid, and vibratomesliced at 300 μm. Slices were transferred onto Millicell-CM slice culture inserts (Millipore) over culture medium (FluoroBrite DMEM with 25% horse serum, 25% HBSS, 1% N2 supplement, 1% penicillin and streptomycin) in glass-bottom 6-well plates and incubated at 37 °C, 5% CO 2 for at least 1 h. The plates were then transferred to an inverted Leica TCS SP5X confocal with an on-stage incubator (while streaming 5% CO 2 , 5% O 2 ), and imaged using a ×10 immersion objective (numerical aperture = 0.3) at specified interval and total imaging time in texts with intermittent repositioning of the focal planes. Lesion boundaries were assessed using DAPI staining following the completion of live imaging. The time-lapse images were processed in Imaris (Bitplane).
Human MS. Human MS postmortem tissue blocks were provided by the UK Multiple Sclerosis Tissue Bank at Imperial College London. All tissues were collected following fully informed consent by the donors via a prospective donor scheme following ethical approval by the London Multicentre Research Ethics committee (MREC 02/2/39). MS lesions were characterized as described previously 30 , using Luxol fast blue to assess demyelination, SMI-31 immunohistochemistry to assess preservation of axons, and LN3 immunohistochemistry to assess inflammatory cell activity. Lesions with florid parenchymal and perivascular inflammatory cell infiltration, myelin fragmentation, and demyelination with indistinct margins were classified as active plaques. Chronic active plaques were classified as those with extensive demyelination, well-demarcated borders, and abundant inflammatory cells at the lesion edge. Chronic inactive plaques were classified as those with extensive demyelination and well-demarcated borders, but few or no inflammatory cells in any part of the demyelinated area. 'Chronic' lesions quantified in Fig. 1o and Supplementary Fig. 1a were chronic inactive areas. Areas of NAWM and NAGM from each patient were also assessed. Areas of NAGM and NAWM did not demonstrate increased inflammatory activity, but it is not possible to completely rule out other subtle pathology in these areas. Cases assessed are described in Supplementary Table. 1.
Dextran-tetramethylrhodamine tracer to assess in vivo barrier function of BBB. Dextran-tetramethylrhodamine tracer (Dextran-Tetramethylrhodamine, 10-kDa, D1817, ThermoFisher) was injected into mice through tail vein injection, and allowed to circulate for 6 h. Brain and spinal cord were then dissected immediately and fixed by immersion fixation overnight in 4% paraformaldehyde (PFA) to immobilize the tracers at the end of the experiment. The dextrantetramethylrhodamine tracer leakage was assessed within frozen sections.
In vitro BBB permeability assay. Primary cultured ECs were cultured on the apical surface of 3-μm pore size, collagen type I and fibronectin precoated Transwell filter inserts (CLS3472, Corning). After treatments, 100 mg ml −1 10-kDa dextran-tetramethylrhodamine was added to the upper chamber. The EC in vitro barrier was then incubated at 37 °C for 1 h. The relative fluorescence intensity of Rhodamine that had passed across the barrier into the lower chamber was measured with a FilterMax F5 microplate reader. Results shown are the mean fluorescence intensity of three independent experiments. The permeability of a blank insert was used as the positive control.
OPC culture and collection of conditioned medium. Mouse OPCs were isolated by immunopanning from P8 APC loxP/loxP mouse and Olig2-cre:APC loxP/loxP mouse cortices as previously described 31 . Briefly, mouse brain cerebral hemispheres were minced and dissociated with papain at 37 °C for 60 min. After trituration, cells were incubated at room temperature sequentially on three immunopanning dishes: Ran-2, GalC, and O4. The purified mouse OPCs were plated onto 10-cm dishes and cultured for another 4 d. The cultured medium was filtered with a 0.22-μm filter (Millipore), then collected as conditioned medium for downstream experiments or stored at −80 °C. The conditioned medium from APC loxP/loxP control OPC cultures was labeled as WT-CM; the conditioned medium from Olig2-cre:APC loxP/loxP OPC cultures was labeled as APC-CM. 
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The optical density values were determined by measuring the absorbance at 450 nm using the microplate reader (Bio-RAD, Model 680). Independent experiments were performed in triplicate.
Western blot. Western blot was also used to quantity Wif1 and Cldn5 expression levels. Protein samples were separated on 10% SDS-PAGE gels, transferred to nitrocellulose membranes, and probed with antibody against Wif1 (1:1,000, rabbit, ab155101, Abcam) or Cldn5 (1:500, mouse, 352588, ThermoFisher). Mouse heart tissue lysate was used as the positive control. Quantification of band intensity was analyzed using the Image-Pro Plus software.
EC culture and treatment. For in vitro EC treatment, primary cultured rat ECs were isolated from P14 Sprague Dawley rat cortices as previously described 32 , and cultured on collagen type I and fibronectin precoated coverslips for immunostaining and 6-cm dishes for quantitative PCR (qPCR). Cultured ECs were treated with recombinant Wif1 (10 μg ml −1 , ab208465, Abcam), recombinant Wnt3a (100 ng ml −1 , 315-20, Peprotech), or Wif1 with Wnt3a for 2 d. PBS was used as control. To test the effects of conditioned media on ECs, cultured ECs were treated with conditioned media with or without Wif1 depletion (25% fresh medium + 75% conditioned medium) for 2 d. qPCR. Total RNA was isolated using RNeasy Plus Mini Kit (74134, Qiagen). qPCR was performed with the C1000 Touch Real-time PCR Detection System (Bio-Rad) and GoTaq qPCR Master Mix (Promega). The oligonucleotide primers, amplification procedure, and melt curve analysis were performed. For each sample, independent repeats were performed in triplicate.
mRNAseq of Olig2-cre:APC loxP/loxP mice. Whole spinal cord was dissected from three Olig2-cre:APC loxP/loxP mice and three APC loxP/loxP littermate control mice at both P4 and P9 time points. An RNAseq library was prepared using QuantSeq kit (Lexogen) according to the manufacturer's instructions and sequenced 50-base pair single-end on the HiSeq 4000 (Illumina). We trimmed adapter from sequence reads using trim galore v0.4.4 with cutadapt v1.14, and used FastQC v0.11.6 to assess quality control for fastq files. Sequence reads were mapped to the mouse genome reference (GRCm38) with gencode annotation (M14) and we counted number of reads using STAR aligner v2.5.0a. A differential expression analysis was performed on read counts using DESeq2. Based on PCA (priniciple component analysis) plot (Supplementary Fig. 14a ) and sample-to-sample distance heatmap, we removed outlier samples that were clustered with different conditions. Pairwise comparisons were performed between Olig2-cre:APC loxP/loxP and APC loxP/loxP littermate controls, and between P4 and P9. We obtained FDR-adjusted P value and log 2 (fold change). Genes were selected by significance threshold of FDR < 0.05, log 2 (fold change) > 1, or log 2 (fold change) < −1.
Quantifications. OPC quantifications.
For the OPC-vessel association analysis, PDGFRα/CD31 double staining was used to detect the association of OPCs with blood vessels. The percentage of PDGFRα + cells with their cell bodies directly in contact with blood vessels was quantified.
To quantify OPC process and blood vessel correlation, we used the Image-Pro Plus 5 software to measure the value of the angle between OPC leading process and blood vessel. This measurement was only done for OPCs in which the cell body was on a blood vessel and the leading process was clearly seen. Oriana software was used to draw the vector map for summarizing the correlation of OPC and blood vessel.
For the OPC leading process direction analysis, we used the Image-Pro Plus 5 software to draw a vector between the OPC cell body and the end of the leading process in the direction of the OPC's leading process. This leading process direction analysis was only done for OPCs in which the cell body was on a blood vessel and the leading process was clearly seen. Oriana software was used to draw the vector maps for summarizing the directionality of OPC migration.
For the qualification of OPC migration in slice cultures, the directionality of OPC migration was measured by Image-Pro Plus 5 and Oriana as described previously. Speed of migration was measured by dividing the total length of OPC movement by the total time. Vector maps show the directions of OPC movement.
For OPC cluster quantification, a 'cluster' constituted 4+ cells in cell body contact.
Quantifications of astrocytic endfeet coverage. To quantify Aldh1L1-GFP astrocytic endfeet coverage, images of areas with blood vessels covered by OPC clusters in :Aldh1l1-GFP control mice were captured for analysis. When the GFP + process was wrapped on/along CD31 + vessels, it was considered an astrocytic endfoot. Quantifications of length of blood vessels and GFP + endfeet were done using Image-Pro Plus 5 software. AQP4 + endfeet coverage quantification was performed in a similar way.
Quantifications of fibrinogen and dye leakage. To identify vascular leakage of fibrinogen or dye, we performed CD31 staining of blood vessels to mark out the edges of vasculature. To quantify the extent of leakage in Olig2-cre:APC loxP/loxP , we measured the fibrinogen or dye immunoreactive areas outside of these blood vessels. Similar areas in non-cre APC loxP/loxP mice were used as control. The fluorescent area quantifications were measured as described below. Fluorescent intensity and area quantifications. To quantify fluorescent-positive area, intensity, and western blot-positive band, the positive areas were automatically selected in Image-Pro Plus 5 software. The areas of interest were separated by setting a threshold at least two times the background. Cell counting and fluorescence intensity analyses were conducted on six randomly chosen fields for each sample using an Image-Pro Plus image analysis system. Statistical analysis. Statistical significance between groups was determined with GraphPad Prism software. The unpaired t-test was used to determine the significance between two experimental groups. One-way analysis of variance (ANOVA) was used to determine the significances among three and four groups. Data distribution was assumed to be normal, but this was not formally tested. A probability of P < 0.05 was considered statistically significant. All significant statistical results are indicated within the figures with the following conventions: *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. Error bars represent ±standard deviation. No statistical methods were used to predetermine sample sizes. The sample size per group was determined from previous publications with similar methodology. Control mice and their littermate mutant mice were collected from different litters, and randomly selected for each experiment. For lesioning experiments using adult control mice, those mice were randomly assigned into different time points as indicated. Investigators were blinded to group allocation during data analysis. All experiments were performed at least three times, and the findings were replicated in individual mice and cell cultures in each experiment. 
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Software and code
Policy information about availability of computer code Data collection R code used for the mRNAseq analysis can be found on the following github page. https://github.com/baranzini-lab/RNAseq_QuantSeq_Fancy Data analysis Microscopy images were prepared using ImageJ/Fiji and Image-Pro plus 6. Live imagings were assembled using Imaris software. Statistical analyses were performed using Prism software. Software used for the mRNAseq data analysis was as follows: Trim Galore v0.4.4 with CutAdapt v1.14, FastQC v0.11.6, STAR aligner v2.5.0a, R version 3.5.1, R packages: Bioconductor version 3.7, DESeq2_1.20.0, ggplot2_3.1.0, RColorBrewer_1.1-2, pheatmap_1.0.10, readr_1.2.1.
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
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The data that support the findings of this study are available from the corresponding author upon request. Raw sequence data (fastq) for the mRNAseq data are available on DASH data share (https://doi.org/10.7272/Q63N21KB).
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Sample size
No statistical method was used in deciding sample sizes. The sample size per group was determined from previous publications with similar methodologies.
Data exclusions In the mRNAseq experiment, we removed one outlier sample from APCfl/fl at P4 and one from Olig2cre:APCfl/fl at P9 since those samples did not cluster with the same experimental group on PCA analysis. No data were excluded from any other analyses.
